Literature DB >> 9764804

The PTEN tumour suppressor gene and malignant melanoma.

R Böni1, A O Vortmeyer, G Burg, G Hofbauer, Z Zhuang.   

Abstract

A candidate tumour suppressor gene, PTEN, has recently been identified within chromosome 10q23, the locus of the Cowden syndrome/Lhermitte Duclos disease susceptibility gene. Cowden disease is an autosomal dominant cancer predisposition syndrome associated with tumours of the breast, thyroid and, less frequently, malignant melanoma. Based on the identification of mutations in sporadic breast, brain and prostate tumours, we decided to examine the potential role of PTEN in sporadic malignant melanoma. Frozen tissue from primary cutaneous melanomas (n = 23) and metastases (n = 17) were microdissected, and microsatellite markers D10S541 and D10S547, flanking the gene on both sides, were used to search for loss of heterozygosity (LOH) in the PTEN gene locus. To identify mutations within the putative tumour suppressor gene, we performed single strand conformation polymorphism (SSCP) analysis using intronic primers to amplify exons 5, 6, 7 and 8 of the PTEN gene. No LOH was detected using the polymorphic markers D10S541 and D10S547. SSCP analysis revealed no aberrant bands in the tumour specimen. Our results suggest that the PTEN gene does not play a major role in the initiation and progression of melanoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764804     DOI: 10.1097/00008390-199808000-00002

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

1.  Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.

Authors:  X P Zhou; O Gimm; H Hampel; T Niemann; M J Walker; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 3.  The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-28       Impact factor: 4.693

4.  Nuclear PTEN levels and G2 progression in melanoma cells.

Authors:  Abraham I Jacob; Todd Romigh; Kristin A Waite; Charis Eng
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

5.  Therapeutic Implications of Targeting AKT Signaling in Melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Enzyme Res       Date:  2011-03-23

6.  PTEN/MMAC1 expression in melanoma resection specimens.

Authors:  M Deichmann; M Thome; A Benner; U Egner; W Hartschuh; H Näher
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.